Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-07 · accession 0001415889-25-012541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-09 | 2025-05-07 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $3.80 | +200 | 57.6K | +0.3% | +$760 |
| D | 2025-05-09 | 2025-05-07 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $27.00 | -200 | 57.4K | -0.3% | -$5,400 |
| D | 2025-05-09 | 2025-05-07 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -200 | 65.9K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-05-07 | M | A | 200 | $3.80 | 57,603 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-05-07 | S | D | 200 | $27.00 | 57,403 | D | — | — | |
| 3 | Derivative | Share Option | 2025-05-07 | M | D | 200 | $0.00 | 65,867 | D | $3.80 · — to 2027-06-28 | 200 Class A Ordinary Share | (F2) The option is fully vested and exercisable. |